Treatment of primary Sjogren's syndrome with low-dose natural human interferon-α administered by the oral mucosal route: A phase II clinical trial

Jonathan A. Ship, Philip C. Fox, Joel E. Michalek, Martin J. Cummins, Alan B. Richards, Ibtisam Al-Hashimi, Ava Wu, Gary M. Kammer, Edward V. Lally, Francis G. LeVeque, Peter B. Lockhart, Michael T. Montgomery, Mahvash Navazesh, Nelson L. Rhodus, Beatrice Gandara, Charles F. Streckfus